Deciphering new concepts of posttranscriptional regulation central to the biology of the human intracellular pathogen Leishmania

解读人类细胞内病原体利什曼原虫生物学核心的转录后调控新概念

• 批准号: 452087
• 负责人: Papadopoulou Barbara
• 金额: $ 74.96万
• 依托单位: CHU de Qubec
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2026-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452087&lang=en
• 关键词: 'Omics' Technologies; 3'Utr Regulatory Elements; Intracellular Parasitism And Pathogenesis; Leishmania; Mrna Decay; Post-Transcriptional Gene Regulation; Ribosome-Associated Quality Control; Rna-Binding Proteins; Rna-Protein Interactions; Translation Regu

Leishmaniasis is one of the 17 neglected tropical diseases affecting close to 2 billion of the world's poorest populations. The disease is caused by the protozoan parasite Leishmania and transmitted to humans by the bite of infected sandflies. Leishmania

利什曼病是17种被忽视的热带疾病之一，影响着世界上近20亿最贫穷的人口。这种疾病是由原生动物寄生虫利什曼原虫引起的，并通过受感染的白蛉的叮咬传播给人类。Leishmania